Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension.
J Hypertens
; 36(3): 462-471, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29135628
ABSTRACT
After examining in Part I the general mechanisms of endothelial cell injury in the kidney, the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension and the Japanese Society of Hypertension will herein review current knowledge on the role of endothelial dysfunction in multiple disease conditions that affect the kidney, including diabetes mellitus, preeclampsia, solid organ transplantation, hyperhomocysteinemia and antiangiogenic therapy in cancer. The few available randomized controlled clinical trials specifically designed to evaluate strategies for correcting endothelial dysfunction in patients with hypertension and/or chronic kidney disease are also discussed alongside their cardiovascular and renal outcomes.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pre-Eclampsia
/
Endothelium, Vascular
/
Endothelin-1
/
Diabetic Nephropathies
/
Renal Insufficiency, Chronic
/
Hypertension
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
Limits:
Animals
/
Female
/
Humans
/
Pregnancy
Language:
En
Journal:
J Hypertens
Year:
2018
Document type:
Article
Affiliation country:
Italy